Newsroom

Sorted by: Latest

-

Pernod Ricard: amélioration séquentielle au T1, dans un environnement contrasté

PARIS--(BUSINESS WIRE)--Regulatory News: Pernod Ricard (Paris:RI): Communiqué - Paris, 15 octobre 2026 à 7h30 Le chiffre d’affaires du premier trimestre de l’exercice 2026/27 s’élève à 2 234 M€. L’effet périmètre de -127 M€ est principalement lié à la cession d’Imperial Blue et des Vins, et l’effet de change de -3 M€ est principalement lié à la roupie indienne et à la livre turque. Le chiffre d’affaires recule de -10% aux États-Unis et de -25% en Chine, ces deux marchés étant affectés, comme at...
-

Pernod Ricard: Sequential Improvement in Q1, in a Contrasted Environment

PARIS--(BUSINESS WIRE)--Regulatory News: Pernod Ricard (Paris:RI): Press Release – Paris, 15 October 2026 at 7.30am Net Sales for Q1 FY27 totalled €2,234m. Perimeter impact of -€127m mainly linked to the disposal of Imperial Blue and Wines, and Foreign Exchange impact of -€3m mainly linked to INR and TRY1. Sales in the US declined by -10% and in China by -25%, with both markets being impacted by inventory adjustments, as expected. Underlying depletions in China returned to growth, confirming th...
-

Largo publie ses résultats semestriels 2026 et son chiffre d’affaires du 3ème trimestre 2026

SAINTE-LUCE-SUR-LOIRE, France--(BUSINESS WIRE)--Regulatory News: Largo (FR0013308582 – ALLGO), acteur industriel français éco-responsable et expert du reconditionnement de produits high-tech, annonce ses résultats semestriels clos le 30 juin 2026 et son chiffre d’affaires du troisième trimestre clos le 30 septembre 2026. Christophe Brunot et Frédéric Gandon, Co-fondateurs de Largo, déclarent : « Le premier semestre 2026 matérialise l’efficacité de la transformation engagée par Largo. Malgré la...
-

Celltrion mettra en avant l'infliximab sous-cutané (Remsima™ SC) et son portefeuille élargi de traitements contre les MICI lors de l'UEG Week 2026

INCHEON, Corée du Sud--(BUSINESS WIRE)--Celltrion, Inc. (KRX :068270) a annoncé sa participation à la Semaine de l’United European Gastroenterology (UEG) 2026, qui se tiendra à Barcelone, en Espagne (du 17 au 20 octobre), afin de mettre en avant son portefeuille de traitements contre les maladies inflammatoires chroniques de l’intestin (MICI), avec en tête de liste le Remsima™ SC (infliximab sous-cutané). Celltrion présentera son portefeuille complet de produits à base d’infliximab, comprenant...
-

Deadline Alert: The Ensign Group, Inc. (ENSG) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming December 7, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired The Ensign Group, Inc. (“Ensign” or the “Company”) (NASDAQ: ENSG) securities between February 10, 2022 and June 18, 2026 inclusive (the “Class Period”).IF YOU SUFFERED A LOSS ON YOUR THE ENSIGN GROUP, INC. INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIA...
-

Tourism Malaysia and Alipay+ Partner to Accelerate Malaysia’s Digital Tourism Transformation

KUALA LUMPUR, Malaysia--(BUSINESS WIRE)--Tourism Malaysia and Alipay+, the unified wallet gateway of Ant International, today signed a Memorandum of Understanding (MoU) to accelerate cross-border commerce and digitalise merchant engagement across Malaysia's tourism economy. As Malaysia welcomes visitors for Visit Malaysia 2026–2027 (VM2026–2027), this partnership merges Tourism Malaysia’s destination marketing with Alipay+’s global wallet ecosystem and AI capabilities. It aims to create a highl...
-

Gibraltar to Sell Infrastructure Business to Saint-Gobain for $208 Million

BUFFALO, N.Y.--(BUSINESS WIRE)--Gibraltar Industries, Inc. (Nasdaq: ROCK), a leading manufacturer and provider of products and services for the residential and agtech markets, today announced that it has entered into an agreement to sell its Infrastructure business, D.S. Brown, to Saint-Gobain for $208 million in cash, subject to customary post-closing adjustments. The sale is expected to close in the fourth quarter of 2026 subject to customary closing conditions, including receipt of required r...
-

PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new phase II data showing that nemolizumab provided meaningful improvements in itch, sleep disturbance, and quality of life in children aged 2 to 11 years with moderate-to-severe atopic dermatitis, sustained through Week 52.1 The results will be presented at The Pediatric Dermatology Research Alliance (PeDRA) Annual Conference. Up to 25% of children are affected by atopic dermatit...
-

Terry Paule Takes SWIM to Abu Dhabi UN Water Conference

ABU DHABI, UAE--(BUSINESS WIRE)--The third UN Water Conference runs 8–10 December 2026 at ADNEC, Abu Dhabi. It focuses on accelerating action on SDG 6 (Clean Water and Sanitation)....
-

Investor Alert: Robbins LLP Informs Investors of the Triller Group Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is investigating whether ILLR failed to disclose that it would be unable to timely file required financial reports with the SEC....